ArticleCell2024

Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.

Yufei Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.